There wasn't too much excitement in Acadia Pharmaceuticals today which only managed to move up 0.37% on the day.
It looks like Acadia Pharmaceuticals isn't currently at a very decisive point in regards to support/resistance levels. Acadia Pharmaceuticals hasn't established a very strong momentum in either direction over the last 3 months. We'll see if a stronger consensus among market participants emerges. ACAD may hit some resistance around the 17.79 level, more sellers may enter the market here and push price back down. But it's definitely not guaranteed.
The analysts feel fairly neutral on the prospects for Acadia Pharmaceuticals but a little more positive than negative. The current Analysts Sentiment Score is 17.58. Most companies range between (-200 to 200).
Here's a break down of the latest rating changes. Needham & Company LLC dropped their price target by -11.11% to $32.00 on 2024-03-12. Mizuho downgraded from Buy to Neutral on 2024-03-12 and decided to decrease their price target by -35.9% down to $25.00. JPMorgan Chase & Co. provided a price target decease of -9.38% to $29.00 from $32.00 on 2024-03-01. Royal Bank of Canada announced a lowering of their price target to $35.00 from $36.00 on 2024-02-28. Cantor Fitzgerald announced that they are reiterating a rating of Overweight on 2024-02-28 and they set their price target at $42.00. On 2024-02-28 HC Wainwright reiterated their rating of Buy and added a price target of $33.00. JMP Securities reiterated a rating of Market Outperform on 2024-02-07 and added a price target of $42.00. Oppenheimer reiterated a rating of Market Perform on 2024-02-05 and added a price target of $25.00. Robert W. Baird announced that they are initiating coverage with a rating of Outperform on 2024-01-30 and provided a price target of $40.00. On 2023-12-19 Morgan Stanley upgraded Acadia Pharmaceuticals from Equal Weight to Overweight and moved up their price target to $40.00 which is a 29.03% increase.
Company | Ratings Score
?
Composite analyst sentiment score
|
Positive Ratings | Negative Ratings | Boost Price Target | Lower Price Target |
---|---|---|---|---|---|
ACAD | 17.58 | 25.77 | -5.92 | 22.24 | -6.93 |
Company | YOY Growth Score (typical -20 to +20) | Revision Directions (-6 to +6) |
---|---|---|
ACAD | 0.00 | 0.00 |
We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.
Company | Short Score (typical 1-15)
?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
|
Short Interest | Days to Cover | Rate of Change | Shares Short |
---|---|---|---|---|---|
ACAD | 4.44 | %4.59252 | 4.7 | -7.326 | 7540000 |
Segment | Count | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest | Analysts Ratings ? |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biotechnology | 95 | 0.79 | -3.72 | -2.26 | -0.85 | 7.67 | 40.04 | 55.08 | 6.66 | 6.30 | 3.43 | -14013.76 | -12974.30 | 16.84 | 4.74 | 9.36 | 8.41 |
Healthcare | 230 | 0.88 | -1.52 | -0.30 | -2.16 | 5.72 | 27.64 | 53.66 | 8.86 | 8.57 | 8.32 | -12704.99 | -11984.82 | 18.91 | 4.24 | 6.74 | 5.55 |
Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.
Ticker | Social Sentiment(1-10) |
---|---|
ACAD |
Company | Score | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest Score |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
XNCR | Xencor, Inc. | 0.86 | 0.38 | 0.94 | 12.10 | 40.02 | -0.13 | 28.22 | 83 | 16.10 | 7.18 | 7.98 | -4734.49 | -11116.17 | 0 | 0 | 15.4823 |
DNLI | Denali Therapeutics Inc. | 0.75 | 0.37 | -2.16 | -6.27 | 0.45 | 27.59 | 35.41 | 69 | 74.38 | 103.30 | 59.38 | 116.84 | -22833.86 | 0 | 0 | 11.2371 |
SAGE | Sage Therapeutics, Inc | 0.69 | 0.00 | -8.57 | -37.45 | -37.85 | -56.63 | -74.61 | 31 | -168.21 | -178.82 | -69.30 | -149709.64 | -1968.67 | 0 | 0 | 12.6533 |
RCKT | Rocket Pharmaceuticals, I | 0.65 | -0.91 | -12.01 | -24.27 | -29.63 | -39.96 | -40.37 | 29 | -88.38 | -65.83 | -77.27 | -23028.56 | -99.38 | 0 | 0 | 9.12889 |
How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.